Cargando…
Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience
To date, a recognized treatment for refractory membranous nephropathy (MN) has not been established. Recently, several reports have indicated the efficacy of rituximab as a novel treatment option. However, only a few published accounts exist of rituximab therapy for idiopathic MN (IMN) in the Asian...
Autores principales: | Katsuno, Takayuki, Ozaki, Takenori, Kim, Hangsoo, Kato, Noritoshi, Suzuki, Yasuhiro, Akiyama, Shinichi, Ishimoto, Takuji, Kosugi, Tomoki, Tsuboi, Naotake, Ito, Yasuhiko, Maruyama, Shoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519470/ https://www.ncbi.nlm.nih.gov/pubmed/28674357 http://dx.doi.org/10.2169/internalmedicine.56.7908 |
Ejemplares similares
-
The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis
por: Hachiya, Asaka, et al.
Publicado: (2021) -
Therapeutic Potential of Stem Cells from Human Exfoliated Deciduous Teeth in Models of Acute Kidney Injury
por: Hattori, Yuka, et al.
Publicado: (2015) -
Correction: Therapeutic Potential of Stem Cells from Human Exfoliated Deciduous Teeth in Models of Acute Kidney Injury
por: Hattori, Yuka, et al.
Publicado: (2015) -
Patient Age and the Prognosis of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014) -
Smoking Is a Risk Factor for the Progression of Idiopathic Membranous Nephropathy
por: Yamaguchi, Makoto, et al.
Publicado: (2014)